Pathological haemostasis and ‘prothrombotic state’ in Behçet's disease
- 1 January 2002
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 105 (2) , 125-133
- https://doi.org/10.1016/s0049-3848(02)00006-3
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic stateAnnals of the Rheumatic Diseases, 2001
- The Endothelium and ThrombosisSeminars in Thrombosis and Hemostasis, 2000
- Fibrin Clot Formation and Lysis: Basic MechanismsSeminars in Thrombosis and Hemostasis, 2000
- Behçet's DiseaseNew England Journal of Medicine, 1999
- Haemostasis, Thrombosis, and Endothelium in Behcet's DiseaseActa Haematologica, 1998
- ACTIVATED PROTEIN C RESISTANCE DUE TO A COMMON FACTOR V GENE MUTATION IS A MAJOR RISK FACTOR FOR VENOUS THROMBOSISAnnual Review of Medicine, 1997
- A peptide derived from a tissue factor loop region functions as a tissue factor-factor VIIa antagonistBiochemistry, 1995
- Behcet’s Syndrome Associated with Minimal Change Glomerulonephritis and Renal Vein ThrombosisNephron, 1989
- Intracranial Hypertension in Behçet's Disease: Demonstration of Sinus Occlusion With Use of Digital Subtraction AngiographyMayo Clinic Proceedings, 1985
- Acute myocardial infarction and recurrent ventricular arrhythmias in Behcet's syndromeAmerican Heart Journal, 1982